Osteopenia News and Research

RSS
Osteopenia is a condition where bone mineral density is lower than normal. It is considered by many doctors to be a precursor to osteoporosis. However, not every person diagnosed with osteopenia will develop osteoporosis. More specifically, osteopenia is defined as a bone mineral density T-score between -1.0 and -2.5.
Studies show vitamin D may benefit cardiovascular, skin and metabolic disorders

Studies show vitamin D may benefit cardiovascular, skin and metabolic disorders

Tarsa advances OSTORA NDA filing through $28M Series B financing

Tarsa advances OSTORA NDA filing through $28M Series B financing

Telephone-based counseling program does not improve osteoporosis medication adherence

Telephone-based counseling program does not improve osteoporosis medication adherence

Research roundup: 'No individual mandate' scenarios; Breaking down health care expenditures

Research roundup: 'No individual mandate' scenarios; Breaking down health care expenditures

Testing for osteoporosis – how often?

Testing for osteoporosis – how often?

Gilead Sciences receives FDA approval for Viread to treat pediatric HIV infection

Gilead Sciences receives FDA approval for Viread to treat pediatric HIV infection

Growth hormone replacement increases bone formation in abdominally obese women

Growth hormone replacement increases bone formation in abdominally obese women

Many spinal fusion surgery patients have low levels of vitamin D

Many spinal fusion surgery patients have low levels of vitamin D

NPS announces new data from GATTEX Phase 3 study on short bowel syndrome

NPS announces new data from GATTEX Phase 3 study on short bowel syndrome

Tarsa reports positive data from OSTORA Phase III ORACAL trial for postmenopausal osteoporosis

Tarsa reports positive data from OSTORA Phase III ORACAL trial for postmenopausal osteoporosis

Positive data from Tarsa's OSTORA Phase III trial on postmenopausal osteoporosis

Positive data from Tarsa's OSTORA Phase III trial on postmenopausal osteoporosis

FDA reviews safety issues of bisphosphonates for osteoporosis

FDA reviews safety issues of bisphosphonates for osteoporosis

NPS submits NDA CMC section to FDA for GATTEX

NPS submits NDA CMC section to FDA for GATTEX

FDA approves Gilead's Complera for treatment of HIV-1 infection

FDA approves Gilead's Complera for treatment of HIV-1 infection

Unigene second quarter revenue decreases to $2.5 million

Unigene second quarter revenue decreases to $2.5 million

Osteoporosis, low bone density common in people with early-stage MS

Osteoporosis, low bone density common in people with early-stage MS

Varicocele surgery may increase testosterone production

Varicocele surgery may increase testosterone production

Low testosterone linked to varicoceles

Low testosterone linked to varicoceles

Zoledronate at lower dose effective in reducing risk of osteoporotic fractures

Zoledronate at lower dose effective in reducing risk of osteoporotic fractures

The Endocrine Society releases clinical practice guideline on Vitamin D deficiency

The Endocrine Society releases clinical practice guideline on Vitamin D deficiency